167 related articles for article (PubMed ID: 33806305)
1. Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells.
Cecchi M; Paccosi S; Silvano A; Eid AH; Parenti A
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806305
[TBL] [Abstract][Full Text] [Related]
2. Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines.
Paccosi S; Cecchi M; Silvano A; Fabbri S; Parenti A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3155-3163. PubMed ID: 32776284
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone Promotes a Stem-Like Phenotype in Human Melanoma Cells
Cecchi M; Mannini A; Lapucci A; Silvano A; Lulli M; Luceri C; D'Ambrosio M; Chiarugi A; Eid AH; Parenti A
Front Pharmacol; 2022; 13():911019. PubMed ID: 35847038
[TBL] [Abstract][Full Text] [Related]
4. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
[TBL] [Abstract][Full Text] [Related]
5. Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process.
Cecchi M; Anceschi C; Silvano A; Coniglio ML; Chinnici A; Magnelli L; Lapucci A; Laurenzana A; Parenti A
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794128
[TBL] [Abstract][Full Text] [Related]
6. Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase.
Yoshioka S; Ikeda T; Fukuchi S; Kawai Y; Ohta K; Murakami H; Ogo N; Muraoka D; Takikawa O; Asai A
Int J Tryptophan Res; 2022; 15():11786469221138456. PubMed ID: 36467776
[TBL] [Abstract][Full Text] [Related]
7. Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond.
Muller AJ; Manfredi MG; Zakharia Y; Prendergast GC
Semin Immunopathol; 2019 Jan; 41(1):41-48. PubMed ID: 30203227
[TBL] [Abstract][Full Text] [Related]
8. High-throughput fluorescence-based screening assays for tryptophan-catabolizing enzymes.
Seegers N; van Doornmalen AM; Uitdehaag JC; de Man J; Buijsman RC; Zaman GJ
J Biomol Screen; 2014 Oct; 19(9):1266-74. PubMed ID: 24870017
[TBL] [Abstract][Full Text] [Related]
9. The effects of a novel and selective inhibitor of tryptophan 2,3-dioxygenase on tryptophan and serotonin metabolism in the rat.
Salter M; Hazelwood R; Pogson CI; Iyer R; Madge DJ
Biochem Pharmacol; 1995 May; 49(10):1435-42. PubMed ID: 7539265
[TBL] [Abstract][Full Text] [Related]
10. Immunological Relevance of the Coevolution of IDO1 and AHR.
Jaronen M; Quintana FJ
Front Immunol; 2014; 5():521. PubMed ID: 25368620
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Tryptophan-Dioxygenase Activity Increases the Antitumor Efficacy of Immune Checkpoint Inhibitors.
Schramme F; Crosignani S; Frederix K; Hoffmann D; Pilotte L; Stroobant V; Preillon J; Driessens G; Van den Eynde BJ
Cancer Immunol Res; 2020 Jan; 8(1):32-45. PubMed ID: 31806638
[TBL] [Abstract][Full Text] [Related]
12.
Yang D; Zhang S; Fang X; Guo L; Hu N; Guo Z; Li X; Yang S; He JC; Kuang C; Yang Q
J Med Chem; 2019 Oct; 62(20):9161-9174. PubMed ID: 31580660
[TBL] [Abstract][Full Text] [Related]
13. Biological and clinical significance of tryptophan-catabolizing enzymes in cutaneous T-cell lymphomas.
Maliniemi P; Laukkanen K; Väkevä L; Dettmer K; Lipsanen T; Jeskanen L; Bessede A; Oefner PJ; Kadin ME; Ranki A
Oncoimmunology; 2017; 6(3):e1273310. PubMed ID: 28405495
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan-catabolizing enzymes - party of three.
Ball HJ; Jusof FF; Bakmiwewa SM; Hunt NH; Yuasa HJ
Front Immunol; 2014; 5():485. PubMed ID: 25346733
[TBL] [Abstract][Full Text] [Related]
15. The catalytic inhibitor epacadostat can affect the non-enzymatic function of IDO1.
Panfili E; Mondanelli G; Orabona C; Gargaro M; Volpi C; Belladonna ML; Rossini S; Suvieri C; Pallotta MT
Front Immunol; 2023; 14():1134551. PubMed ID: 37122718
[TBL] [Abstract][Full Text] [Related]
16. Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma.
Terai M; Londin E; Rochani A; Link E; Lam B; Kaushal G; Bhushan A; Orloff M; Sato T
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32050636
[TBL] [Abstract][Full Text] [Related]
17. 4,6-Disubstituted-1H-Indazole-4-Amine derivatives with immune-chemotherapy effect and in vivo antitumor activity.
Huo C; Luo Z; Ning X; Kang X; Yan Q; Guo Y; Li G; Wang Z; Li Y; Qian S
Eur J Med Chem; 2022 Nov; 241():114625. PubMed ID: 35952399
[TBL] [Abstract][Full Text] [Related]
18. Suppression of TDO-mediated tryptophan catabolism in glioblastoma cells by a steroid-responsive FKBP52-dependent pathway.
Ott M; Litzenburger UM; Rauschenbach KJ; Bunse L; Ochs K; Sahm F; Pusch S; Opitz CA; Blaes J; von Deimling A; Wick W; Platten M
Glia; 2015 Jan; 63(1):78-90. PubMed ID: 25132599
[TBL] [Abstract][Full Text] [Related]
19. Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.
Pilotte L; Larrieu P; Stroobant V; Colau D; Dolusic E; Frédérick R; De Plaen E; Uyttenhove C; Wouters J; Masereel B; Van den Eynde BJ
Proc Natl Acad Sci U S A; 2012 Feb; 109(7):2497-502. PubMed ID: 22308364
[TBL] [Abstract][Full Text] [Related]
20. Indoleamine 2,3-dioxygenase 1 deficiency attenuates CCl4-induced fibrosis through Th17 cells down-regulation and tryptophan 2,3-dioxygenase compensation.
Zhong W; Gao L; Zhou Z; Lin H; Chen C; Huang P; Huang W; Zhou C; Huang S; Nie L; Liu Y; Chen Y; Zhou D; Lv Z
Oncotarget; 2017 Jun; 8(25):40486-40500. PubMed ID: 28465467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
